COVID-19: Current Status and Future Prospects
On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic, and the disease now affects nearly every country and region. Nearly 18 months later, COVID-19, caused by SARS-CoV-2, continues to present significant challenges to health systems, public health, and the economy of c...
Saved in:
Other Authors: | , , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_98978 | ||
005 | 20230405 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230405s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-6741-9 | ||
020 | |a 9783036567402 | ||
020 | |a 9783036567419 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-6741-9 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
072 | 7 | |a MMG |2 bicssc | |
100 | 1 | |a Leggat, Peter |4 edt | |
700 | 1 | |a Frean, John |4 edt | |
700 | 1 | |a Blumberg, Lucille |4 edt | |
700 | 1 | |a Leggat, Peter |4 oth | |
700 | 1 | |a Frean, John |4 oth | |
700 | 1 | |a Blumberg, Lucille |4 oth | |
245 | 1 | 0 | |a COVID-19: Current Status and Future Prospects |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (354 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic, and the disease now affects nearly every country and region. Nearly 18 months later, COVID-19, caused by SARS-CoV-2, continues to present significant challenges to health systems, public health, and the economy of countries across both hemispheres. The morbidity and mortality of the infection caused by SARS-CoV-2 has been significant, and various waves of disease outbreaks initially overwhelmed hospitals and clinics in many countries and continue to do so. This influences everyone, and public health countermeasures have been dramatic in terms of their impact on employment, social systems, and mental health. This Special Issue collection follows on from the Special Issue "COVID-19: Current Challenges and Future Perspectives" and provides an avenue for authors from various disciplines to provide feedback on the response to and our future global preparedness for COVID-19, as well as to disseminate critical information about SARS-CoV-2 and the associated COVID-19 pandemic. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
650 | 7 | |a Pharmacology |2 bicssc | |
653 | |a COVID-19 | ||
653 | |a new-onset DM | ||
653 | |a severe infection | ||
653 | |a mortality | ||
653 | |a outbreak | ||
653 | |a P.1 variant | ||
653 | |a Gamma variant | ||
653 | |a SARS-CoV-2 infection | ||
653 | |a whole-genome sequencing | ||
653 | |a pandemic | ||
653 | |a overweight | ||
653 | |a obesity | ||
653 | |a Peru | ||
653 | |a psychological impacts | ||
653 | |a public health | ||
653 | |a preparedness | ||
653 | |a mRNA-1273 | ||
653 | |a BNT162b2 | ||
653 | |a TAK-919 | ||
653 | |a SARS-CoV-2 | ||
653 | |a post-vaccination | ||
653 | |a healthcare personnel | ||
653 | |a vaccination | ||
653 | |a asymptomatic infection | ||
653 | |a HIV | ||
653 | |a infectious disease | ||
653 | |a excess mortality | ||
653 | |a regdanvimab | ||
653 | |a remdesivir | ||
653 | |a severe | ||
653 | |a community transmission | ||
653 | |a population density gradient | ||
653 | |a Dhaka | ||
653 | |a Bangladesh | ||
653 | |a dengue | ||
653 | |a undifferentiated febrile illness | ||
653 | |a antigen testing | ||
653 | |a variants | ||
653 | |a reinfections | ||
653 | |a breakthrough infections | ||
653 | |a vaccine hesitancy | ||
653 | |a sub-Saharan Africa | ||
653 | |a pulmonary fibrosis | ||
653 | |a postacute COVID-19 syndrome | ||
653 | |a tuberculosis | ||
653 | |a helminth coinfection | ||
653 | |a coronavirus | ||
653 | |a coordination | ||
653 | |a health operations and technical expertise | ||
653 | |a AFRO | ||
653 | |a diarrhea | ||
653 | |a liver | ||
653 | |a pancreas | ||
653 | |a inflammatory bowel diseases | ||
653 | |a liver transplantation | ||
653 | |a reproduction rate | ||
653 | |a phylogenetic analysis | ||
653 | |a clade GK | ||
653 | |a D614G | ||
653 | |a P681R | ||
653 | |a cross-reactivity | ||
653 | |a haemorrhage | ||
653 | |a thrombocytopenia | ||
653 | |a thrombosis | ||
653 | |a severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) | ||
653 | |a molecular diagnostics | ||
653 | |a real-time polymerase chain reaction (RT-qPCR) | ||
653 | |a economy | ||
653 | |a income levels | ||
653 | |a waves | ||
653 | |a policy | ||
653 | |a turning points | ||
653 | |a occupational exposure | ||
653 | |a risk factors | ||
653 | |a personal protective equipment | ||
653 | |a SIR model | ||
653 | |a socio-behavioral aspects | ||
653 | |a interaction distance | ||
653 | |a school reopening strategy | ||
653 | |a self-medication | ||
653 | |a over-the-counter | ||
653 | |a medicine use | ||
653 | |a Pakistan | ||
653 | |a clinical features | ||
653 | |a Luanda | ||
653 | |a Angola | ||
653 | |a socioeconomic status | ||
653 | |a risk perception | ||
653 | |a risk prevention practices | ||
653 | |a qualitative | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7040 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/98978 |7 0 |z DOAB: description of the publication |